重性抑郁障碍
耐受性
增食欲素
医学
临床前研究
认知
精神科
神经科学
药理学
临床心理学
心理学
内科学
受体
不利影响
神经肽
医学物理学
作者
Kyle Valentino,Kayla M. Teopiz,Sabrina Wong,M Zhang,Gia Han Le,Hayun Choi,Hana Ballum,Christine E. Dri,William W. L. Cheung,Roger S McIntyre
标识
DOI:10.1080/14728214.2025.2452514
摘要
Early clinical evidence suggests that seltorexant is effective in treating MDD, both in individuals diagnosed with insomnia and those not, although greater antidepressant effects are observed in individuals with severe sleep disturbance. Results from large phase III clinical trials are needed to confirm efficacy and safety.
科研通智能强力驱动
Strongly Powered by AbleSci AI